Item 4. Controls and Procedures.

Controls and Procedures.

We,

under the

supervision and

with the

participation of

our management,

including our

Chief Executive

Officer and

Chief Financial

Officer,

have

evaluated

the

effectiveness

of

the design

and

operation

of

our

disclosure

controls

and

procedures

(as

defined

in

Rule

13a-15(e)

under

the

Securities

Exchange

Act

of

1934).

Based

on

our

evaluation,

our

Chief

Executive

Officer

and

Chief

Financial

Officer have concluded

that, as of February

26, 2023, our disclosure

controls and procedures were

effective to ensure

that information

required to

be disclosed

by us

in reports

that we file

or submit

under the

Securities Exchange

Act of

1934 is (1)

recorded, processed,

summarized,

and

reported

within

the

time

periods

specified

in

Securities

and

Exchange

Commission

rules

and

forms,

and

(2)

accumulated and

communicated to

our management,

including our

Chief Executive

Officer and

Chief Financial

Officer,

in a

manner

that allows timely decisions regarding required disclosure.

There were no changes in our internal

control over financial reporting (as defined

in Rule 13a-15(f) under the Securities Exchange

Act

of 1934) during

the quarter ended February

26, 2023 that materially

affected, or are

reasonably likely to

materially affect, our

internal

control over financial reporting.

PART

II.

OTHER INFORMATION

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds.

The

following

table

sets forth

information

with

respect

to

shares

of

our

common

stock

that we

purchased

during

the quarter

ended

February 26, 2023:

Period

Total

Number

of Shares

Purchased (a)

Average

Price Paid

Per Share

Total

Number of Shares

Purchased as Part of a Publicly

Announced Program (b)

Maximum Number of Shares

that may yet be Purchased

Under the Program (b)

November 28, 2022 -

January 1, 2023

1,961,407

$

84.61

1,961,407

88,860,531

January 2, 2023 -

January 29, 2023

1,016,544

82.85

1,016,544

87,843,987

January 30, 2023 -

February 26, 2023

2,330

77.99

2,330

87,841,657

Total

2,980,281

$

84.00

2,980,281

87,841,657

(a)

The total number

of shares purchased

includes shares of

common stock withheld

for the payment

of withholding taxes

upon the distribution

of

deferred option units.

(b)

On June

27, 2022,

our Board

of Directors

approved a

new authorization

for the

repurchase of

up to

100,000,000 shares

of our

common stock

and terminated

the prior

authorization. Purchases

can be

made in

the open

market or

in privately

negotiated transactions,

including the

use of

call options

and other

derivative instruments,

Rule 10b5-1

trading plans,

and accelerated

repurchase programs.

The Board

did not

specify an

expiration date for the authorization.

PART

II. OTHER INFORMATION